Company: CHNR
Filing Date: 2025-01-27
Form Type: POS AM
Source: 0001079973-25-000143
Chunk: 71

Company: CHINA NATURAL RESOURCES INC
Filing Date: 2025-01-27
Form: POS AM
Chunk 71
---
 unrelated parties, there is no assurance that such is the case or will be so in the future, or that
shareholders would not be better protected if we were not exempt from, or we chose to voluntarily comply with, the applicable Nasdaq
rules.

| 38 |

Risks Relating to Our Common Shares

You may experience dilution to the extent that our Common Shares are issued upon the exercise of outstanding warrants or other securities that we may issue in the future.

You may
experience dilution to the extent that our Common Shares are issued upon the exercise of our outstanding warrants, and if we issue
additional equity securities, or there are any issuances and subsequent exercises of stock options issued in the future. Up to
1,115,903 Common Shares may be issued with the exercise of warrants at a per share exercise price of $3.00 issued to the investors
and up to 74,394 Common Shares may be issued with the exercise of warrants at a per share exercise price of $2.20 issued to the
placement agent in a private placement (the “February 2024 Private Placement”) in connection with the February 2024
Registered Offering. See “ – Description of Warrants.”

Substantial future sales or perceived potential sales of our Common Shares in the public market could cause the price of our Common Shares to decline.

Sales of our Common
Shares in the public market, or the perception that these sales could occur, could cause the market price of our Common Shares to decline.
As of the date of this prospectus, we have 9,865,767 Common Shares issued and outstanding. On February 16, 2024, the Company entered
into a securities purchase agreement with certain institutional investors (the “Investors”), pursuant to which the Company
agreed to issue and sell, (i) in a registered direct offering, up to an aggregate of 1,487,870 of common shares, no par value of the
Company at a per Share purchase price of $2.20, and (ii) in a concurrent private placement, warrants initially exercisable for the purchase
of an aggregate of 1,115,903 common shares of the Company, for gross proceeds of approximately $3.01 million, before deducting fees to
the placement agent and other estimated offering expenses payable by the Company. In connection will the Registered Offering and Private
Placement pursuant to the terms of a placement agency agreement, dated February 16, 2024 between the Company and Placement Agent,